Irinotecan Liposome for Resectable Pancreatic Cancer With or Without Addebelizumab
Clinical trial NCT06172036 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06172036
- Sponsor
- Zhejiang University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-20
- Primary completion
- 2026-01-20
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.